Tag: NASDAQ:ADAP

Business

New Insights About Adaptimmune Therapeutics Plc ADR (ADAP)

Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP) concluded the trading at $1.44 on Friday, March 22, with a rise of 7.46% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $1.34 and 5Y monthly